ARCHIVES

Drugs and Targets: FDA approves Velcade in mantle cell lymphoma

This article is from The Cancer Letter archive.

Vol. 40 No. 39 | October 17, 2014

Download PDF Visit The Full Archive

Related Articles

FDA Updates Safety Labeling Of 5-Alpha Reductase Inhibitors

June 24, 2011

Abstracts From AACR Annual Meeting

May 21, 1976

NCI Seeks Prevention Fellows.

March 9, 2001

In Brief: Hellman To Head DCT board; Gard Joins Colorado Group; NCI May Support Death Index

September 12, 1980

PSA Velocity Poor Predictor Of Prostate Cancer Occurrence

March 25, 2011

In Brief: Christopher Walsh Named Dana-Farber President; Sachs Leaves NCI; Acoustic Neuroma Conference

August 16, 1991